Wednesday, February 10, 2010, 4:22am EST - Canadian Markets open in 5 hours and 8 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Telik Inc. (TELK)

 On Feb 9: 0.91 USD   0.00 (0.00%)  
MORE ON TELK
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
Telik, Inc. (NCM:TELK) Delayed quote dataEdit
Last Trade: 0.91 USD
Trade Time: Feb 9
Change: 0.00 (0.00%)
Prev Close: 0.91
Open: N/A
Bid: N/A
Ask: N/A
1y Target Est: 2.00
Day's Range: N/A - N/A
52wk Range: 0.27 - 1.40
Volume: 0
Avg Vol (3m): 205,592
Market Cap: 48.62M
P/E (ttm): N/A
EPS (ttm): -0.37
Div & Yield: N/A (N/A%)
Telik Inc. (TELK)
1d  5d  3m  6m  1y  2y  5y  max 
 Add TELK to Portfolio   Download Data

HEADLINES
• Telik Announces Presentation and Webcast at 12th Annual BIO CEO & Investor Conference
PRNewswire (Mon, Feb 1)
• Telik Announces Initiation of Phase 1 Clinical Study of Ezatiostat Hydrochloride (TELINTRA(R), TLK199) Tablets in Combination With Lenalidomide (Revli
PRNewswire (Mon, Jan 25)
• TELIK INC Financials
EDGAR Online Financials (Sat, Jan 9)
• TELIK INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfe
EDGAR Online (Wed, Jan 6)
• TELIK INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfe
EDGAR Online (Mon, Dec 28)
• New Star Analyst Rankings for Telik, Inc.
StarMine (Mon, Nov 16)
• TELIK INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
EDGAR Online (Fri, Nov 13)
• Telik Announces Third Quarter 2009 Financial Results
PRNewswire (Fri, Nov 13)
• Icahn Should Hang It Up: Activist
at TheStreet.com (Wed, Oct 28)
• [video] Accenture's Sales Drop
at Forbes.com (Thu, Oct 1)
More Headlines for TELK...
ANALYST
EPS Est (next year) (Dec-09) : -0.48
EPS Est (in 2 years) (Dec-10) : -0.45
Avg Rec (current)*: 3.0
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Telik, Inc., a clinical stage drug development company, focuses on discovering and developing small molecule drugs to treat cancer and inflammatory diseases.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices